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Behaviors and underlying brain circuits show characteristic changes across the lifespan that produce sensi-
tive windows of vulnerability and resilience to psychopathology. Understanding the developmental course of
these changes may inform which treatments are best at what ages. Focusing on behavioral domains and
neurobiological substrates conserved from mouse to human supports reciprocal hypothesis generation
and testing that leverages the strengths of each system in understanding their development. Introducing hu-
man genetic variants into mice can further define effects of individual variation on normative development,
how they contribute to risk and resilience for mental illness, and inform personalized treatment opportunities.
This article emphasizes the period of adolescence, when there is a peak in the emergence of mental illness,
anxiety disorders in particular. We present cross-species studies relating fear learning to anxiety across
development and discuss how clinical treatments can be optimized for individuals and targeted to the bio-
logical states of the developing brain.Neurodevelopmental Framework
The brain is an extremely dynamic organ, displaying dramatic
differences in gene expression, neurogenesis, neural circuit for-
mation and maturation, and behavior across the lifespan (Lee
et al., 2014). Developmental changes in brain and behavior
have evolved to facilitate the completion of stage-specific pre-
rogatives: forming nurturing bonds in infancy, juvenile explora-
tion of the environment, and the formation and maintenance of
stable relationships in adulthood. Adaptive changes across
normative development can lead to imbalances that predispose
to or protect from mental illness in interaction with individual
genetic factors and environmental exposures. Enhancing clin-
ical outcomes requires an appreciation of neurodevelopmental
changes in brain and behavior across diverse behavioral do-
mains and treating the individual by targeting their develop-
mental strengths.
Our neurodevelopmental framework considers three interre-
lated concepts that contribute to distinct peaks in incidence
of different psychiatric disorders: developmental trajectory,
dynamic interaction of systems, and sensitive periods (Casey
et al., 2014). Developmental trajectory refers to the course of
brain and behavioral changes over time. Behavioral domains
and their neural substrates display different developmental
profiles, and these normative courses must be defined to under-
stand how the relative strengths and liabilities of different devel-
opmental stages contribute to the characteristic age of onset of
different disorders and, in particular, the high incidence ofmental
illness in adolescence (Figure 1).
Behavior results from the coordinated activity of diverse neural
structures through complex neural circuits. Dynamic interaction
of systems refers to the fact that circuit function and behavior
will vary across time as different components of neural circuits
mature according to different trajectories. As structures and
the tracts connecting them mature at different rates, relative1358 Neuron 86, June 17, 2015 ª2015 Elsevier Inc.imbalances can occur, particularly during adolescence when
emotional behaviors are biased toward subcortical drive due to
the late maturation of the prefrontal cortex (Casey et al., 2008;
Gogtay et al., 2004). These developmental imbalances are
adaptive but create vulnerabilities that, when exacerbated by
biological, environmental, and genetic factors, give rise to a
cascade of more complex deficits as subsequent brain regions
mature and interact with a dysregulated system (Masten and
Cicchetti, 2010).
Finally, neural and behavioral plasticity is not fixed. During
development, there are temporally limited ‘‘sensitive periods’’
of heightened plasticity during which different neural systems
and behavior are particularly receptive to different types of
experience. The visual system displays a very distinct sensitive
or critical period for stimulus-induced plasticity, providing an
opportunity to define the mechanisms of transient plasticity
and identify methods to manipulate it (Hensch, 2004; Knudsen,
2004). The systems regulating fear and anxiety also display sen-
sitive periods (Nabel and Morishita, 2013), and these times of
enhanced plasticity create a vulnerability to pathogenic experi-
ences and provide windows of opportunity when therapeutic in-
terventions may be particularly successful (Lee et al., 2014).
Development of Fear and Anxiety
As anxiety disorders are the most common psychiatric illnesses
in youths, affecting as many as 1 in 10, and these diagnoses
peak in adolescence (Kessler et al., 2005), we focus here on un-
derstanding and treating these disorders from a neurodevelop-
mental perspective. A core feature of anxiety disorders is diffi-
culty identifying when situations that have been experienced
as threatening in the past are currently safe. Based on principles
of fear extinction learning, exposure-based cognitive behavioral
therapy (CBT) focuses on desensitization through repeated ex-
posures to fear triggers in a safe context. This process relies
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Figure 1. Developmental Emergence of Mental Disorders
Based on data from Kessler et al. (2005) and Kessler and Wang (2008). ADHD,
attention deficit hyperactivity disorder; Schiz, schizophrenia.
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velopmental changes from childhood to adulthood (Gee et al.,
2013; Hare et al., 2008) and likely contributes to both develop-
mental and individual differences in anxiety and its treatment.
In this context, 40%–50% of youths with anxiety disorders do
not respond to exposure-based CBT treatment (Walkup et al.,
2008). Rodent and human studies suggest that fear extinction
learning is diminished during adolescence (Kim et al., 2011;
McCallum et al., 2010; Pattwell et al., 2012b) relative to child-
hood and adulthood and that this diminished extinction stems
from altered neuroplasticity in the prefrontal cortex in adoles-
cents (Pattwell et al., 2012b). Moreover, alterations in sensitive
periods may contribute to the onset of anxiety, constraining
the flexibility and repertoire of mechanisms for fear reduction
among adolescents with anxiety disorders. In this article, we
highlight how changes in brain development during the transi-
tions into and out of adolescence and individual genetic variation
impact the capacity for emotion regulation and dysregulation in
anxiety disorders. Based on these findings, we provide a frame-
work for using age and genetics to devise novel therapeutic and
preventative strategies to maximize effectiveness in treating
these disorders.
Neural Circuits for Fear Learning and Regulation
A core feature of anxiety disorders is difficulty learning which
cues and contexts signal safety and which signal a threat (Char-
ney and Manji, 2004; Duman et al., 1997; Nestler et al., 2002;
Pine, 2007). Fear learning involves making associations between
previously experienced negative events and the cues and con-
texts that predicted their occurrence. Experimental studies
typically model this associative learning using Pavlovian condi-
tioning paradigms, in which a neutral cue is paired with an
intrinsically aversive stimulus. This pairing produces a learned
association between the previously neutral cue, now the condi-
tioned stimulus (CS), and the aversive unconditioned stimulus
(US), which enables the CS to elicit a range of physiological
and behavioral conditioned responses (CRs) to the anticipated
threat. In experimental studies of rodents, the most typical
CR assessed is freezing. In humans, common CRs includechanges in skin conductance, startle responses, and pupil dila-
tion. Although learned fear memories are persistent, their behav-
ioral expression can be inhibited through new learning that a
once threatening stimulus is now safe. Experimentally, this pro-
cess of extinction learning is modeled by repeatedly presenting
the CS without the aversive US and is typically accompanied
by a gradual decrease in the expression of the CR. The persis-
tence of the original fearmemory is evidenced by the fact that ex-
tinguished fear often returns under a number of circumstances,
including a change in context (renewal), exposure to an aversive
stimulus (reinstatement), or the mere passage of time (sponta-
neous recovery) (Bouton et al., 2006).
The circuitry involved in fear regulation in the adult brain has
been delineated in both human imaging and rodent studies
(Phelps et al., 2004; LeDoux, 2000). The amygdala is the core
structure involved in fear acquisition and expression of learned
fear memories. In-depth anatomical, electrophysiological, and
neuroimaging studies have detailed the various components of
the amygdala and their roles in fear learning and memory. In
standard auditorily cued fear conditioning, projections from the
cortex and thalamic nuclei receiving sensory inputs converge
on the lateral nucleus of the amygdala (LA) simultaneously
(Collins and Pare´, 2000; Quirk et al., 1995; Sotres-Bayon et al.,
2006). The LA and the basal nucleus of the amygdala (BA) serve
as the primary fear-learning interface and collectively integrate
the relevant sensory information and relay it to the central nu-
cleus (CE). Serving as the amygdala’s secondary interface, the
CE elicits fear responses through downstream projections to hy-
pothalamic and brain stem nuclei to engage autonomic re-
sponses (Maren, 2001). The cytoarchitecture of the amygdala
is complex. The basolateral amygdala (BLA) contains primarily
glutamatergic projection neurons, whereas the medial CE con-
tains primarily GABAergic neurons with amedium spiny neuronal
morphology (Ehrlich et al., 2009). During fear acquisition, projec-
tions from the hippocampus (specifically the CA1 region) also
provide information to the BA about the surrounding environ-
ment (Bouton et al., 2006). Hippocampal BA integration of
contextual information about the surrounding environment has
a major influence on downstream CE activity and subsequent
fear responses (Fanselow and Dong, 2010; Maren, 2001).
During fear extinction learning, prefrontal cortical regions
are important for appropriately adjusting behaviors when the
emotional significance of a given cue changes (Sotres-Bayon
et al., 2006). The ventromedial prefrontal cortex (vmPFC) in
particular has been shown to be important for making the switch
from fear expression to fear suppression during fear extinction
learning and retention (Milad and Quirk, 2002; Pare´ et al.,
2004; Santini et al., 2004). Distinct subregions within the vmPFC
have been differentially implicated in the expression and extinc-
tion of conditioned fear (Santini et al., 2008; Sierra-Mercado
et al., 2011; Sotres-Bayon and Quirk, 2010). Specifically, the
dorsally located prelimbic cortex (PL) is associated with the
production of conditioned fear responses and expression of
conditioned fear behaviors (Corcoran and Quirk, 2007), whereas
the more ventrally located infralimbic cortex (IL) is associated
with suppression of conditioned fear responses (Burgos-Robles
et al., 2009; Hefner et al., 2008; Knapska and Maren, 2009).The
infralimbic cortex can dampen fear responses via projections toNeuron 86, June 17, 2015 ª2015 Elsevier Inc. 1359
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dala. These inhibitory intercalated cells modulate activity in the
central nucleus, thereby suppressing the CE output and damp-
ening downstream physiological processes associated with
the fear response (Berretta et al., 2005; Likhtik et al., 2008).
The hippocampus also plays a critical role in fear extinction, as
it modulates frontoamygdala function by supplying contextual
information about the degree of threat or safety in the environ-
ment (Fanselow and Dong, 2010; Orsini andMaren, 2012), which
is accomplished via projections from the ventral CA1 hippocam-
pus to the BA (Fanselow and Dong, 2010; Orsini et al., 2011).
Whether experienced as safe or threatening, these hippocam-
pus-BA connections can modulate subsequent fear responses
via projections to the CE. Connections between the ventral
CA1 hippocampus and vmPFC (IL) modulate extinction learning
by detecting contextual cues in the surrounding environment
(Hugues and Garcia, 2007; Rosas-Vidal et al., 2014; Sierra-Mer-
cado et al., 2011). In addition, recent studies in rodents demon-
strate that the ventral CA1 also directly inhibits PL activity only
after extinction training, presumably by activating interneurons
in the PL (Sotres-Bayon et al., 2012). In sum, the neural circuitry
underlying fear expression and regulation involves complex in-
teractions among the frontolimbic brain circuitry, and variation
in the connectivity of this circuitry may impact its function.
Sensitive Periods for Fear Learning and Regulation
Although multiple studies across species have delineated a fairly
detailed model of the neurocircuitry supporting fear learning
and extinction in adulthood, there has been less focus on the
neurodevelopment of these functional circuits. The prefrontal
and subcortical circuitry implicated in adult fear learning
undergoes substantial developmental change from childhood
through adulthood (Gogtay et al., 2004; Lenroot and Giedd,
2006; Raznahan et al., 2014; Sowell et al., 1999). Mirroring these
pronounced changes in the brain, numerous studies to date sug-
gest that fear learning and regulation exhibit qualitative changes
across development.
Infantile Sensitive Period for Fear Learning
In rodents, fear learning emerges early in postnatal development
and is linked to the maturation of the amygdala (Landers and
Sullivan, 2012). Prior to postnatal day 10 (P10), infant rats exhibit
a paradoxical approach response to an odor stimulus previously
paired with shock (Camp and Rudy, 1988; Sullivan et al., 2000).
This early postnatal period corresponds to a sensitive period for
attachment learning, and the suppression of fear responding
during this periodmay functionally promote attachment between
the infant and caregiver, even if the quality of care received is
poor (Landers and Sullivan, 2012). After P10, odor-shock condi-
tioning produces a conditioned odor aversion, reflecting the
emergence of cued fear learning. This behavioral change coin-
cides with the onset of learning-induced synaptic plasticity
within the amygdala (Thompson et al., 2008). However, P12–
P15 rodent pups exhibit a persistent odor preference when
paired with a shock in the presence of the mother but odor aver-
sion in the absence of the mother; maternal presence led to the
suppression of pup corticosterone and its regulation of amyg-
dala activity (Moriceau and Sullivan, 2006). Even when animals
have developed the ability to learn conditioned aversion, early1360 Neuron 86, June 17, 2015 ª2015 Elsevier Inc.fear memories remain qualitatively different from those of adults
in that they are not as persistent. Conditioned fear learned at P18
appears to be forgotten within 10 days (Campbell and Spear,
1972; Kim and Richardson, 2007). Conversely, fear memories
conditioned at P23 do not degrade but are highly susceptible
to interference, showing persistent attenuation following extinc-
tion learning, a pattern not seen in older animals (Pattwell et al.,
2012b). Notably, this ‘‘infantile amnesia’’ for fear memories is
experience-dependent and modulated by conditions of early-
life stress. Animals that have experienced chronic maternal sep-
aration at P17 exhibit full recall of fear 10 days later (Callaghan
and Richardson, 2011). Contextual fear conditioning in rodents
emerges later than cued fear learning (Akers et al., 2012; Rudy,
1993). Although P17 rats do not appear to extend learned fear
associations to the broader surrounding environment, adult-
like contextual fear conditioning emerges by P24. It has been
shown recently that neurogenic waves in the hippocampus in in-
fant rodents prevent contextual fear memory persistence (Akers
et al., 2012). The emergence of contextual fear learning and
memory may reflect increased maturation of the hippocampus
and its connections to the amygdala (Raineki et al., 2010).
Juvenile Sensitive Period for Fear Extinction
As with acquisition and retrieval of fear learning, extinction
learning also changes markedly across development, especially
during the transition through the juvenile period. Extinction
training in pre-weanling animals (prior to P24) produces the
typical decrease in fear expression. Unlike adult animals, these
animals do not exhibit the fear re-emergence phenomena that
typically occur following extinction training (Gogolla et al.,
2009; Kim and Richardson, 2007; Yap and Richardson, 2007).
This lack of spontaneous recovery, reinstatement, and renewal
suggests that fear memories at this developmental stage are
fragile or vulnerable to interference and may depend less on IL
input (Kim and Richardson, 2008). However, as stated above,
we have shown that, in P23 rodents, memories do not degrade
on their own, but, rather, are highly susceptible to interference
and paralleled by IL potentiation during extinction learning (Patt-
well et al., 2012b). Nonetheless, both studies show persistent
attenuation of the fear memory (e.g., lack of spontaneous recov-
ery or reinstatement of fear memory), unlike in older rodents, in
which the recovery of fear typically occurs.
Developmental critical periods in the visual system have been
related to maturation of the extracellular matrix surrounding
fast-spiking GABAergic interneurons that express parvalbumin
(PV). In particular, the formation of perineuronal nets (PNNs), an
organized form of chondroitin sulfate proteoglycan-containing
extracellular matrix, initiates critical period closure in the visual
cortex (Berardi et al., 2003; Pizzorusso et al., 2002). A significant
increase in PNNs has been observed in the amygdala during the
juvenile time frame, which is the precise time frame for the transi-
tion from the juvenile form of fragile fear memory to the more
adult-like state in which recovery of extinguished fear typically
occurs (Gogolla et al., 2009). There are twopossiblemechanisms
by which PNNs might prevent fear memory erasure. PNNs may
stabilize fear memories by rendering potentiated synapses re-
sistant to reversal of long-term potentiation, or PNN formation
might give rise to changes in local GABA-mediated inhibition.
The latter mechanism is plausible given that PNNs form primarily
A B Figure 2. Development of Cued Fear
Extinction Parallels Clinical Response to
Cognitive Behavioral Therapy in Anxiety
Disorders
(A) Reduced fear extinction learning in both mice
and humans during adolescence (Pattwell et al.,
2012b). *, adolescent extinction is significantly
less than childhood and adulthood extinction.
(B) Diminished treatment response during adoles-
cence based ondata from theCAMS (Walkup et al.,
2008), subdivided by developmental stage. Ado-
lescents show a nonsignificant decrease in
responsiveness to cognitive behavioral therapy
(Drysdale et al., 2014).
All results are presented as means ± SEM.
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GABAergic neurotransmission mediates several forms of BLA
synaptic plasticity (Duvarci and Pare, 2014). Moreover, structural
degradation of these PNNs in adulthood reintroduces a juvenile-
like state in which extinction results in a persistent attenuation of
fear memory (Gogolla et al., 2009).
Adolescent Sensitive Period for Fear Extinction
In contrast to the ease with which fears are diminished in these
younger animals, both fear extinction learning and retention are
attenuated during adolescence (Kim et al., 2011; McCallum
et al., 2010; Pattwell et al., 2012b; Figure 2A). Relative to pre-
and post-adolescent animals, adolescents exhibit diminished
fear extinction learning that is paralleled by an absence of
extinction-learning-induced plasticity within the IL (Pattwell
et al., 2012b). Adolescent rats require either more extinction tri-
als or a pharmacological intervention, such as the NMDA re-
ceptor modulator, d-cycloserine, to achieve reductions in fear
expression comparable with younger or older rats (McCallum
et al., 2010). This blunted fear extinction during adolescence
is associated with a lack of activity in the prefrontal cortex, spe-
cifically IL, as assessed by phospho-mitogen-activated protein
(MAP) kinase immunohistochemistry (Kim et al., 2011) or c-Fos
immunohistochemistry (Pattwell et al., 2012b) compared with
younger and older ages. Electrophysiological recordings at IL
and PL synapses across development reveal that a fear condi-
tioning-induced potentiation of PL synapses present in adult
mice is absent in adolescent mice. Furthermore, extinction-
induced enhancement of IL synaptic plasticity in adult mice is
lacking in adolescent mice (Pattwell et al., 2012b). These
studies suggest that the development of cued fear extinction
progresses in a nonlinear manner, with adolescents showing
diminished extinction learning relative to preadolescents and
adults.
Adolescence is a time of exploration when one must leave the
safety of his or her familial environment to attain reproductive
success. As specific danger cues remain relevant during this
novelty-seeking period, cued fear expression remains intact
and is resistant to extinction during adolescence. The pro-
nounced structural remodeling of subcortical-prefrontal connec-
tions (e.g., myelination, synaptic pruning) that occurs during
adolescence is likely to contribute to these qualitative shifts in
fear regulation (Somerville and Casey, 2010). For example, there
is substantial pruning of neurons projecting from the IL to the
basal amygdala from adolescence to adulthood (Cressman
et al., 2010). Changes in connectivity between both the amyg-dala and the hippocampus and the vmPFC during adolescence
may initiate the shift from the restricted subcortical circuitry gov-
erning fear learning in juvenile stages toward the more flexible
and expansive circuit for fear regulation that is evident in adult-
hood.
Human studies of fear learning across development have
been somewhat limited by the methodological constraints
involved in designing effective aversive learning paradigms
that are ethical to conduct in children. Typically, these para-
digms use unconditioned stimuli such as white noise, unpleas-
ant images, or a combination of the two (Casey et al., 2013;
Shechner et al., 2014). As in rodents, fear extinction in humans
is also selectively attenuated during adolescence relative to
children and adults (Pattwell et al., 2012b; Figure 2A). To date,
no functional imaging studies of fear extinction across develop-
ment have been reported, but a recent fMRI study examining
developmental changes in connectivity between the medial
prefrontal cortex and the amygdala found that blood oxygen
level-dependent (BOLD) activity within the vmPFC and the
amygdala begins to shift from a positive to a negative correla-
tion from childhood to adolescence that is then stabilized during
adulthood (Gee et al., 2013). These functional connectivity mea-
sures provide an indication of the pronounced maturational
changes in the dynamic interaction between these regions dur-
ing adolescence.
In a remarkable contrast to cued fear associations, which
appear particularly prominent during adolescence due to ineffi-
cient extinction learning, adolescents appear to be insensitive
to contextual fear conditioning. Unlike juvenile and adult mice,
adolescent mice returned to the context in which they experi-
enced an aversive event do not display a fear response (Pattwell
et al., 2011). This suppression of contextual fear during adoles-
cence is due to a failure of contextual fear retrieval as opposed
to acquisition because the same animals tested in early adult-
hood display a fear response to the context. This finding
demonstrates that the developmental course of subdomains of
behavior may be very different, with implications for the develop-
ment and treatment of psychopathology.
Impact of Common Polymorphisms across Development
Although the genome is largely static across the lifespan, the
phenotypic expression of genetic polymorphisms can vary dur-
ing development (Casey et al., 2009). Common genetic polymor-
phisms act by imposing quantitative changes in gene function.
The impact of these molecular effects on higher-level brain andNeuron 86, June 17, 2015 ª2015 Elsevier Inc. 1361
Figure 3. Cross-Species Approach to
Individual Variation in Behavior
Introducing common genetic polymorphisms into
the mouse genome supports parallel studies of
brain structure and function using species-spe-
cific techniques across levels of biology. Poly-
morphic effects on conserved behaviors cross-
validate and refine results from each species.
Analysis of gene 3 development interactions can
be identified in mice, and specific hypotheses can
be tested in humans.
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and neural systems that interact with polymorphic genes are at a
critical developmental threshold. Common polymorphisms may
act by altering developmental trajectories, shifting windows of
risk and resilience to earlier or later ages or widening or constrict-
ing these developmental windows, ultimately impacting the risk
for psychopathology and the efficacy of specific treatments.
Understanding the effects of common genetic variation on the
development of different behavioral domains and relating those
changes to psychopathology is valuable because common poly-
morphisms have potential as biomarkers, guiding personalized
psychiatric medicine. However, human behavioral genetic asso-
ciation studies are very challenging because human samples
contain a lot of heterogeneity in terms of their various life expe-
riences and genetic background, which can confound genetic
associations. Moreover, understanding the development of
behavioral domains would require large numbers of subjects of
a wide range of ages to be assessed.
To address the difficulties of human genetic association
studies, we developed a strategy in which individual human poly-
morphisms are introduced into the genomes of inbred mice
through genetic knockin techniques (Glatt and Lee, 2015;
Figure 3). The resultingmice recapitulate the detailed phenotypic
effects of the human variant allele and can be compared with
wild-type mice if they express the ancestral human allele. These
mice can then be subjected to detailed, invasive, and controlled
analysis to identify the effects of the polymorphism on pheno-
types across the biological spectrum from molecule to signaling
pathway, neural, and circuit function and, ultimately to behav-
ioral domains and human pathology-like behaviors such as
exploratory behavior under threat. Polymorphic effects identified
in mice can then be used to design, refine, interpret, and validate
human genetic association studies. Leveraging cross-species
translation and integration across multiple levels of analysis
enhances the reliability and precision of behavioral genetic asso-
ciations, a necessary first step in developing them as clinical bio-
markers.
Such humanized polymorphic mice greatly facilitate gene 3
development studies because large numbers of mice on iden-
tical genetic backgrounds can be studied at any number of
developmental ages. Experiential variables such as stress can
also be controlled and manipulated to ensure that environ-
mental factors that might impact behavior and development
are normalized across genotypes and can be studied system-
atically.1362 Neuron 86, June 17, 2015 ª2015 Elsevier Inc.Knockin Mouse Models of BDNF Val66Met and FAAH
C385A
We began to implement this approach by focusing on two com-
mon functional polymorphisms in genes that have central roles in
major signaling systems in the brain and that have been impli-
cated in learning and memory, and fear memory processes in
particular: Brain-derived neurotrophic factor (BDNF) and fatty
acid amide hydrolase (FAAH). These molecules display unique
patterns of expression across development that may contribute
to the developmental differences in attributes of fear memories
and may also create windows where the effects of polymorphic
variation are particularly pronounced or attenuated (Figure 4).
BDNF is a growth factor acting through TrkB tyrosine kinase re-
ceptors to promote neuronal survival and differentiation. It is also
critical for experience-dependent synaptic plasticity andmemory,
including fear learning (Andero and Ressler, 2012; Chao, 2003).
Loss of BDNF expression in adult genetic knockout mice leads
to impaired fear learning and increased anxiety-related behaviors
(Chen et al., 2006). Clinically, serotonin-selective reuptake inhibi-
tor (SSRI)-induced increases in BDNF expression are required
for their anxiolytic effects (Duman and Monteggia, 2006). Endog-
enous levels of BDNF in the brain rise dramatically starting at
P10 in mice and peak between P20 and P30 (Figure 4A), a time
period that corresponds with the transition from juvenile to
adolescent forms of fear memories (Katoh-Semba et al., 2007;
Kolbeck et al., 1999). The developmental coincidence of in-
creased BDNF levels with the onset of inefficient extinction
learning and retention is intriguing because, in adulthood, BDNF
has been established to play key roles in cued fear extinction (Pe-
ters et al., 2010). These BDNF developmental findings provide
further evidence that extinction behavior in adolescence may be
regulated by different signaling systems than those in adulthood.
Human populations contain a common nonsynonymous poly-
morphism coding for the replacement of the conserved valine
66 with a methionine residue (BDNF Val66Met, rs6265). This
substitution has been shown to lead to decreased activity-depen-
dent BDNF secretion in vitro. In adulthood, genetic knockin of
the variant Met allele caused decreased dendritic complexity,
reduced hippocampal volume, and caused an SSRI-resistant in-
crease in anxiety-related behaviors (Chen et al., 2006).
FAAH is the major catabolic enzyme for the endocannabinoid
anandamide (AEA), an agonist for CB1 receptors in the brain
(Ahn et al., 2009). Reduced FAAH activity due to genetic
knockout or pharmacologic inhibition knockout lead to dramatic
increases in AEA in the brain, accompanied by enhanced fear
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Figure 4. Developmental Expression of BDNF and Components of
the Endocannabinoid System in the Brain
Both systems peak in adolescence and may contribute to unique attributes of
fear learning during this stage. The effects of BDNF Val66Met (A) and FAAH
C385A (B) across development are presented as dotted lines.
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FAAH expression displays a transient decrease during adoles-
cence, with a trough of expression occurring between P30 and
P40 (Figure 4B), slightly later than the BDNF peak between the
juvenile to peri-adolescent timeframe (P2,535) (Lee and Gor-
zalka, 2012; Lee et al., 2013) than the BDNF peak. AEA levels
display inverse changes across development, consistent with
FAAH as its major catabolic mechanism. In addition, there is a
concomitant transient increase in expression of CB1 receptors
in cortical and subcortical regions in this same time frame,
suggesting that there is overall enhanced endocannabinoid
signaling during adolescence. There is a common human C/A
polymorphism at position 385 of the FAAH protein coding
sequence (FAAH C385A, rs324420) that leads to replacement
of a conserved proline residue at position 129 with a threonine,
which destabilizes the FAAH protein, leading to lower steady-
state levels of FAAH expression (Sipe et al., 2002) and, as
we have demonstrated recently, increased AEA in the brain (Din-
cheva et al., 2015).Parallel Mouse and Humans Studies of BDNF Val66Met
and FAAH C385A SNP Fear Extinction Learning
The rich basic science literature relating BDNF and FAAH to cued
fear extinction learning combined with an understanding of the
molecular phenotypes of BDNF Val66Met and FAAH C385A
allowed us to form a priori hypotheses of how the polymor-
phisms would affect fear extinction learning. Specifically, we
hypothesized that the BDNF Met allele, by reducing BDNF
signaling, would reduce the efficiency of fear extinction learning
and that the FAAH A allele, by increasing levels of extinction-
facilitating AEA, would enhance fear extinction learning.
To test these hypotheses, we conducted parallel studies in
polymorphic knockin mice and human population samples using
species-specific versions of fear conditioning paradigms. We
confirmed our hypotheses for both genes in both model sys-
tems. The BDNF Met allele was associated with reduced fear
extinction learning in human carriers (Met homozygotes and
heterozygotes versus Val homozygotes) (Figure 5A). In mice,
controlled breeding allowed the generation of large numbers of
animals of each genotype, which supported the identification
of an additive effect of the Met allele (Soliman et al., 2010).
That information can inform the analysis of future human associ-
ation studies of BDNF Val66Met. The FAAH A allele was associ-
ated with enhanced fear extinction learning in human carriers,
and, in contrast to the BDNF Met allele, in mice, the A allele
appeared dominant, causing similar enhancement extinction
learning of heterozygotes and homozygotes (Dincheva et al.,
2015; Figure 5B).
Frontoamygdala Circuitry
As with the behavioral analysis of fear extinction learning, we
generated a priori hypotheses based on the understanding of
the neurocircuitry underlying fear responses and the observed
extinction learning phenotypes. We then implemented a variety
of species-specific techniques to assess functional and struc-
tural connectivity in the frontoamygdala circuit as a function of
genotype. Specifically, we hypothesized that impaired extinction
learning related to the BDNF Met allele would be accompanied
by reduced connectivity from the prefrontal cortex and amyg-
dala. Conversely, we hypothesized that the FAAH A allele would
be associated with enhanced frontoamygdala connectivity.
In human subjects who were scanned with fMRI during fear
extinction learning, the BDNF Met allele was associated with
decreased activation of the vmPFC and increased amygdala
activation, consistent with the behavioral effects of the BDNF
Met allele. Structural connectivity in the frontoamygdala circuit
was assessed by diffusion tensor imaging (DTI). The BDNF
Met allele was associated with reduced fractional anisotropy, re-
flecting white matter density in the uncinate fasiculus connecting
the vmPFC and amygdala. Inmice, extinction-induced activation
of the vmPFC was assessed by c-Fos expression, which also
showed hypoactivation of vmPFC neurons in response to extinc-
tion learning in BDNF Met allele mice. Electrophysiological anal-
ysis of spike timing-induced plasticity in the infralimbic cortex of
wild-type and BDNF Met mice identified reduced enhancement
of post-synaptic responses involving both N-methyl-D-aspar-
tate and g-aminobutyric acid receptors (Pattwell et al., 2012a).
We also tested the structural and functional effects of the
FAAH C385A polymorphism on the frontoamygdala circuitry. InNeuron 86, June 17, 2015 ª2015 Elsevier Inc. 1363
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B Figure 5. Individual Variation in Cued FearExtinction Learning
(A) Extinction learning is attenuated in humans
with the BNDF Met (M) allele relative to the non-
Met allele(V), as measured by the change in
galvanic skin response. **p < 0.01.
(B) This finding is paralleled in BDNF SNP knockin
mice, measured by less change in freezing
behavior with repeated presentation of the con-
ditioned stimulus alone during extinction trials
*p < 0.05 (VV versus VM/MM). Adapted with
permission from Soliman et al. (2010).
(C) Extinction learning is enhanced in humans with
the FAAH A allele relative to the C allele, as
measured by a greater change in galvanic skin
response. *p < 0.05
(D) This finding is paralleled in FAAH SNP knockin
mice, measured by decreased freezing behavior
with repeated presentation of the conditioned
stimulus alone during extinction trials. **p < 0.01
homozygous knockin mice versus wild-type con-
trols; p < 0.05 heterozygotes versus wild-type.
Adapted with permission from Dincheva et al.
(2015).
All results are presented as means ± SEM.
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Reviewhumans, we examined the resting state connectivity between
the subgenual vmPFC and amygdala and the dorsal anterior
cingulate cortex (ACC) and amygdala. FAAH A allele carriers
showed region-specific increases in correlated BOLD signals
in the vmPFC and the bilateral amygdala. In mice, invasive tract
tracing allowed a more detailed assessment of the neuroana-
tomical location and directionality of genotypic differences in
the frontoamygdala circuitry (Dincheva et al., 2015). We injected
anterograde and retrograde tracers into the IL and quantified
tracer transport to the basolateral amygdala. The FAAH A allele
induced a selective increase in the anterograde tracer density
of IL to BLA but no effect on BLA-to-IL tracer density. This
selective increase in descending IL-amygdala projections pro-
vides a neuroanatomical basis for the increased functional con-
nectivity in the frontoamygdala circuitry in human A allele carriers
and may help explain reported genotypic differences in fear
regulation.
Gene 3 Development Interactions
In addition to identifying the effects of BDNF Val66Met and FAAH
C385A on fear extinction learning and the supporting frontoa-
mygdala circuit, the cross-species studies demonstrated that
knockin mice with common human variant alleles recapitulate
human phenotypes at complex levels of biology and behavior.
This validation opens the door to using polymorphic knockin
mice in exploratory analyses to identify the detailed effects of
common polymorphisms across behavioral domains and devel-
opmental stages to ultimately develop genetic biomarkers to
enhance developmentally informed interventions and treatment
selections. Exploring gene 3 development interactions in mice
offers many advantages over human studies, including a homo-1364 Neuron 86, June 17, 2015 ª2015 Elsevier Inc.geneous genetic background, controlled
breeding of known genotypes, the
ability to control environmental expo-
sures across development, and invasiveanalyses. The ability to perform controlled experiments on hu-
man polymorphisms in a validatedmodel system should improve
the reliability of human behavioral association studies to the
point where they can be more effectively translated to clinical
practice (Lee et al., 2014; Glatt and Lee, 2015).
We recently used BDNF Val66Met mice to extend our earlier
studies of the adolescent suppression of contextual fear ex-
pression (Pattwell et al., 2011). In those studies, we found that
hippocampus-dependent contextual fear associations can be
efficiently acquired during adolescence but not retrieved until
adulthood. We have shown previously that adult BDNF Met
mice have a deficit in acquisition of contextual fear associations,
perhaps related to high BDNF dependence of hippocampal plas-
ticity, reflected in its high level of BDNF expression. As a result,
BDNF Met mice that undergo contextual fear learning in adoles-
cence do not display fear responses to the context in adulthood
whereas wild-type mice do (Dincheva et al., 2014). This finding
demonstrates the complexity of the interactions betweenmolec-
ular function, development, and behavioral sub-domains and
that a polymorphismmay confer both risk and resilience for anx-
iety, depending on the timing and nature of fear exposures.
A detailed assessment of BDNF Val66Met and FAAH C385A
mice across the lifespan will determine how these polymor-
phisms alter the developmental course of fear learning. These
effects may be to shift developmental trajectories to older or
younger ages; expand particular developmental stages; or alter,
expand, or close sensitive periods of development. All of these
effects can influence the risk for and therapeutic opportunities
to treat anxiety disorders. Ultimately, exploratory analyses in
polymorphic mice can generate and refine hypotheses for asso-
ciation testing in human population samples.
A B C 
Figure 6. Diminishing Need for Prefrontally Mediated Extinction to Reduce Fear Memory in Adolescents
(A and B) In adolescence, acquisition of cued-fear associations is similar (A) to adults (*p < 0.05 early versus late trials), but (B) extinction is diminished (difference
in early versus late extinction trials reduced *p < 0.05) potentially contributing to the risk for anxiety disorders and response to treatment.
(C) Extinction of fear associations during reconsolidation can reduce fear memories in adolescents similar to adults (difference in fear response with versus
without reminder cue, p < 0.05) between suggesting that adding reconsolidation to exposure-based therapy for adolescents might improve clinical response.
Adapted with permission from Johnson and Casey (2015).
All results are presented as means ± SEM.
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The developmental changes we described in fear learning be-
haviors and their underlying neurocircuitry help to explain the
discrete peak in incidence for anxiety disorders in adolescence.
Individual genetic variation can alter normative development and
interact with development to alter the risk for or timing of anxiety.
Age and genetics can also affect how well an individual may
respond to treatments that target these fear learning behaviors.
As a result, an appreciation for the developmental stage and
genetic composition can enhance the targeting of treatments
to individuals with the greatest capacity to benefit from them,
enhancing clinical outcomes.
The Child/Adolescent Anxiety Multimodal Study (CAMS) com-
pared treatments in individuals aged 7–17 with diagnoses of sep-
aration anxiety, generalized anxiety disorder, or social phobia
(Walkup et al., 2008). Across this age range, they found that CBT
consisting of 14 sessions of training in anxiety management skills
followed by behavioral exposure to anxiety-provoking situations
performed similarly as pharmacotherapy consisting of the SSRI
sertraline, both of which performed better than a placebo. Combi-
nation sertraline and CBT therapy was associated with higher
response rates than either treatment alone, which may have bio-
logical significance beyond simply ‘‘more is better’’ because
SSRIs have been shown to enhance behavioral and neural plas-
ticity, including retention of fear extinction, and can even re-estab-
lish visual plasticity in adulthood outside of the normal visual crit-
ical period (Hensch and Bilimoria, 2012; Karpova et al., 2011).
Motivated by the hypothesis that diminished fear extinction in
adolescence would hinder the response to exposure-focused
CBT relative to children and adults, we reanalyzed these clinical
trial data to compare treatment responses in three develop-
mental groups and confirmed that the adolescent age group dis-
played nonsignificant lower rates of treatment response than
children (Walkup et al., 2008) or adults (Davidson et al., 2004;
Drysdale et al., 2014; Figure 2B). This result suggests that anxi-ety in adolescents may be better treated through modalities that
do not depend upon fear extinction learning or may require more
intensive extinction-based treatments, and/or may require com-
bination therapy with an SSRI to enhance the typically inefficient
extinction processes in adolescence.
Individual genetic factors can also affect the response of anx-
iety disorders to behavioral therapies. Our previous report of
cross-species effects of the BDNF Val66Met polymorphism on
fear extinction learning led Felmingham et al. (2013) to genotype
subjects with posttraumatic stress disorder (PTSD) treated with
exposure-based therapy. They found, as predicted, that BDNF
Met allele carriers responded less well than Val allele homozy-
gotes. This finding suggests that genotyping patients with
PTSD and perhaps other anxiety disorders may determine treat-
ment decisions. Carriers of the BDNF Met allele may require
more intensive exposure-based therapies or might be more
amenable to validated therapies that emphasize the normal-
ization of interpersonal relationships and, presumably, work
through distinct neural mechanisms (Markowitz et al., 2015).
Finally, recent studies have shown an alternative method
for attenuation of fear memories beyond basic fear extinction
learning: that of memory reconsolidation update (Monfils
et al., 2009; Schiller et al., 2010). Memory reconsolidation is
based on the principle that memories are dynamic rather than
stable and that every time a memory is retrieved, it returns to
a fragile state and must be restabilized or become diminished.
Recent human imaging studies suggest that reconsolidation of
fear memory is primarily mediated by the amygdala rather than
on the prefrontal circuitry (Agren et al., 2012; Schiller et al.,
2013). These findings suggest a plausible way in which adoles-
cents may be able to overcome pathologic fear memories via
interventions that alter memories within the amygdala, such
as reconsolidation update. We recently compared the retention
of a fear memory after extinction learning with and without
a preceding reminder cue in both adolescents and adultsNeuron 86, June 17, 2015 ª2015 Elsevier Inc. 1365
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Review(Johnson and Casey, 2015). We found that, even though ado-
lescents displayed reduced fear extinction relative to adults,
those who were required to retrieve the fear association prior
to extinction learning (i.e., reconsolidation) had a dramatically
reduced fear memory the next day compared with extinction
only. In fact, adolescent fear memories were diminished to
the same degree as they were in adults (Figure 6). Although
extinction learning involves the encoding of a new competing
memory that leaves the original fear memory intact, the current
results suggest that the safety information provided during
post-retrieval extinction (reconsolidation update) is integrated
into the original fear memory, altering its affective value even
in the absence of fear extinction learning. Therefore, incorpo-
rating memory reconsolidation update into exposure therapies
for anxiety may improve the outcomes for adolescents.
Implication/Future Directions
We are at a point in time of both tremendous opportunity and
obligation to advance our understanding of how to treat the
developing brain (Lee et al., 2014). By understanding sensitive
windows of development when the brain is especially receptive
to the environment, we may be able to understand shifts and
early closures of these windows due to environmental or genetic
factors and potentially expand them behaviorally and/or phar-
macologically. Moreover, we could shift our focus from targeting
immature brain systems based on adult human and animal
research toward more developed or dynamic/plastic circuitry
to enhance the efficacy of our treatments. These efforts to guide
novel interventions will require bridging across humans and an-
imalmodel systems at the genetic, molecular, circuit, and behav-
ioral levels. This approach will allow more precision in targeting
treatments by the age and genetic makeup of the individual
and, together, with policies for modifying the environment, will
ultimately diminish the high psychological and economic toll of
mental illness on young people, their families, and society.
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